Letter to the EditorErdafitinib Overcomes FGFR3-TACC3–Mediated Resistance to Osimertinib
Under an Elsevier user license
open archive
Cited by (0)
© 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc.